The Costs of Interrupting Antihypertensive Drug Therapy in a Medicaid Population
Bibliographic Data
| ID | 9099996 |
|---|---|
| Authors | Jeffrey S McCombs (University of Southern California, corresponding author), Michael B Nichol (0000-0003-4989-9806, University of Southern California, corresponding author), Cecelia M Newman (University of Southern California), David A Sclar (0000-0002-0983-4293, Washington State University) |
| Year | 1994 |
| Volume | 32 |
| Issue | 3 |
| Pages | 214-226 |
| Publication date | 1994-03-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | Medical Care (JOURNAL) |
| Journal identifiers | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Publisher | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/00005650-199403000-00003 |
| PMID | 8145599 |
| OpenAlex | W1969856937 |
| Language | EN |
| Citations received | 5 |
| References cited | 1 |
This research explores the association between the interruption or termination of antihypertensive drug therapy and total health care costs among non-institutionalized Medicaid patients older than age 40 who survive the first year after treatment. Multivariate regression analysis was used to estimate the statistical relationship between post-treatment costs and patient demographic characteristics, prior use of services, the type of medication used as initial therapy and whether the patient maintained continuous therapy. Paid claims data from the California Medicaid (Medi-Cal) program were used in the analysis. Total cost of health care in the first year after the initiation of drug therapy was the primary outcome variable. Components of total costs (e.g., hospital, outpatient and physician services, prescription drugs) were also investigated. Nearly 86% of new antihypertensive drug therapy patients interrupted or discontinued purchasing any form of antihypertensive medication during the first year. Patients with interrupted antihypertensive drug therapy consumed an additional $873 per patient (P < .0001) in health care during the first year, not counting a reduction in prescription drug cost of $281 (P < .0001). Increased costs were primarily due to increased hospital expenditures of $637 (P < .0002)
Ambulatory care · Antihypertensive drug · Blood pressure · Drug · Environmental health · Family medicine · Health care · Intensive care medicine · Medicaid · Medical prescription · Medication therapy management · Multivariate analysis · Pharmacist · Pharmacotherapy · Population · Prescription drug · Psychiatry · Blood Pressure and Hypertension Studies · Emergency Medicine · Health Systems, Economic Evaluations, Quality of Life · Internal Medicine · Medicine · Pharmaceutical Practices and Patient Outcomes · Pharmacology · Pharmacy
The assessment of refill compliance using pharmacy records
Differences in Adherence to Antihypertensive Medication Regimens According to Psychiatric Diagnosis
Compliance with antihypertensive therapy among elderly Medicaid enrollees
Medicare Beneficiaries??? Management of Capped Prescription Benefits
Association of Antihypertensive Medication Adherence With Healthcare Use and Medicaid Expenditures for Acute Cardiovascular Events
| Unique citing works | 5 |
|---|---|
| Citations per year | 0,17 |
| Citation span | 1996 - 2016 (21) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 5 |